Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting

Core Insights - Zimmer Biomet Holdings, Inc. is set to launch the Z1 Femoral Hip System for total hip arthroplasty at the 2024 AAHKS annual meeting, showcasing its advanced hip portfolio and enabling technologies [1][4] Group 1: Product Launch and Features - The Z1 Femoral Hip System is a triple-taper femoral system designed to enhance stability and efficiency in total hip arthroplasty, complementing the G7 Acetabular System [1][2] - The Z1 System offers collared and collarless options for cementless applications and includes three distinct neck options to accommodate various patient anatomies [2] - The system is designed to minimize the instrument footprint, thereby reducing processing and sterilization burdens for surgical teams [2] Group 2: Clinical Feedback and Innovations - Initial user feedback from surgeons indicates that the Z1 System is intuitive and versatile, enhancing the surgical experience compared to earlier models [3] - Zimmer Biomet has expanded its hip portfolio through strategic acquisitions, including OrthoGrid Systems, which provides AI-powered surgical assistance applications [3] - The OrthoGrid Hip AI technology offers real-time intra-operative guidance for optimal surgical outcomes, further enhancing the capabilities of the Z1 System [3] Group 3: Upcoming Presentations and Studies - At the AAHKS meeting, Zimmer Biomet will present data from three clinical studies related to hip arthroplasty, focusing on metal ion levels, clinical outcomes, and quality of life correlations [4]